UCLA Thousand Oaks Primary & Specialty Care

Clinical research site in Thousand Oaks, California

Part of UCLA

As of July 2026, 1 paid clinical trial is recruiting at UCLA Thousand Oaks Primary & Specialty Care in Thousand Oaks, California. Active studies at this site focus on Urothelial Carcinoma alongside other indications. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at UCLA Thousand Oaks Primary & Specialty Care (1)

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

for Urothelial Carcinoma

144 locations incl. Gilbert

Sponsor: Seagen, a wholly owned subsidiary of Pfizer

Sex: All·Age: 18+

Code: NCT04879329·Phase 2·Recruiting·Listed May 2021

Apply to this trial

More research sites in Thousand Oaks

Los Robles Regional Medical Center (9 trials)
Clinical Trials Research Institute (4 trials)
Cohen Medical Centers (4 trials)
Los Robles Hospital & Medical Center (3 trials)
Clinical Trials Management Services (3 trials)
Care Access Research (2 trials)
Clinical Trials Management Services, Merz Investigational (2 trials)
Los Robles Medical Center (2 trials)
The Cohen Medical Centers (2 trials)
805 Dentistry (1 trial)

Explore more

Paid clinical trials in Thousand Oaks, CA · California clinical trials